Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/biologic-and-systemic-agents-in-dermatology/descriptif_3859692
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3859692

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Biologic and Systemic Agents in Dermatology, Softcover reprint of the original 1st ed. 2018

Langue : Anglais

Coordonnateur : Yamauchi Paul S.

Couverture de l’ouvrage Biologic and Systemic Agents in Dermatology

Written by leading experts in the field and designed for dermatologists and residents, this book includes evidence-based medicine that underscores the clinical data, as well as practical tips on how to use both biologic and systemic agents in the field of dermatology. In the past decade, there have been several groundbreaking advances in medical dermatology. Novel biologic and systemic agents have been developed to treat inflammatory disorders, including psoriasis and atopic dermatitis, as well as skin malignancies such as melanoma.

Biologic and Systemic Agents in Dermatology encompasses these developments by describing the mechanism of action of these various agents and the clinical efficacy and safety to treating these respective disorders. The utilization of biologic and systemic agents in other dermatologic conditions, pharmacoeconomics, pharmacovigilance, and clinical trials outcomes are discussed as well as topics including tumor necrosis, conventional systemic agents for psoriatic disease, and oral agents for atopic dermatitis.

Chapter 1 – Tumor Necrosis Factor Inhibition in the Treatment of Psoriasis and Psoriatic Arthritis


Chapter 2 – Therapies Targeting Interleukin-23 in Psoriatic Disease


Chapter 3 – Interleukin 17 – Pathogenesis in Psoriatic Disease and Treatment through Selective        Blockade


Chapter 4 – Conventional Systemic Agents for Psoriatic Disease 


Chapter 5 – The Role of JAK Kinase Inhibitors in Psoriatic Disease and Other Dermatologic Conditions


Chapter 6 – PDE4 Inhibition in the Treatment of Psoriasis Disease and Other Skin Conditions


Chapter 7 – Miscellaneous Use of Biologic and Systemic Agents in Other Dermatologic Conditions


Chapter 8 – Targeting Interleukin 4 and Interleukin 13 in the Treatment of Atopic Dermatitis


Chapter 9 – Oral Agents for Atopic Dermatitis


Chapter 10 – Role of Intravenous Immunoglobulin in Dermatologic Disorders


Chapter 11 – Selective Targeting of CD20 on B Cells in Pemphigus Vulgaris and Other Dermatologic Diseases


Chapter 12 – Oral Systemic Agents for Various Immunobullous Disorders


Chapter 13 – Anti-IgE Therapy in Dermatology


Chapter 14  - Oral Retinoids in Dermatology


Chapter 15 – Updates in Immunotherapies for Melanoma


Chapter 16 – Sonic Hedgehog Inhibition in the Treatment of Advanced BCC 

Paul S. Yamauchi, M.D., Ph.D. is Clinical Assistant Professor of Dermatology, David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center and isdermatologist in private practice at the Dermatology Institute and Skin Care Center in Santa Monica, California. Dr. Yamauchi is a fellow with the American Academy of Dermatology and the American Society of Dermatology Surgery and is also a member of the Los Angeles Metropolitan Dermatologic Society and California Society of Dermatology and Dermatologic Surgery.  He is the editor-in-chief of Dermatology Reports and is the author and co-author of more than 70 publications, including several books.
 
Dr. Yamauchi conducts numerous clinical research trials at the Clinical Science Institute in Santa Monica and serves as a principle investigator in several studies, including new therapies for psoriasis, skin cancer, eczema and acne, and has been a consultant for the development of new innovative therapies in dermatology.
 
He is recognized as a key expert leader on psoriasis and has served on the Medical Board for the National Psoriasis Foundation and the Scientific Advisory Committee for the National Eczema Association. He has extensive experience using the new biologics, oral drugs, and topical medications in the treatment of psoriasis, and has been invited as a speaker at international, national, regional, and local venues to talk about new advances in the treatment of psoriasis and atopic dermatitis. In addition, he is a  strong advocate in establishing patient support groups for psoriasis, and has published extensively in new advances in the treatment of psoriasis. Dr. Yamauchi has also spoken on other dermatologic conditions at national and local meetings and has published many peer-reviewed articles including acne, eczema, skin manifestations associated with rheumotologic conditions, and hyperhidrosis.
 
He  has given several television media

Written by leading experts in the field for dermatologists and dermatology residents

Describes the mechanism of action of various systemic and biologic agents, as well as their clinical efficacy and safety

Includes evidence-based medicine that underscores clinical data

Includes practical tips on how to use these agents

Topics covered include tumor necrosis, conventional systemic agents for psoriatic disease, and oral agents for atopic dermatitis

Date de parution :

Ouvrage de 574 p.

21x27.9 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

137,14 €

Ajouter au panier

Date de parution :

Ouvrage de 574 p.

21x27.9 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

189,89 €

Ajouter au panier